Lrig1 Mouse 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of LRIG1 mRNA CTD PMID:26682919 Lrig1 Mouse 1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of LRIG1 mRNA CTD PMID:28960355 Lrig1 Mouse 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRIG1 mRNA CTD PMID:22206623 Lrig1 Mouse 1,2-dimethylhydrazine decreases expression EXP 6480464 1,2-Dimethylhydrazine results in decreased expression of LRIG1 mRNA CTD PMID:22206623 Lrig1 Mouse 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LRIG1 mRNA CTD PMID:17942748 Lrig1 Mouse 17beta-estradiol multiple interactions ISO RGD:1315602 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of LRIG1 mRNA CTD PMID:30165855 Lrig1 Mouse 17beta-estradiol increases expression ISO RGD:1315602 6480464 Estradiol results in increased expression of LRIG1 mRNA CTD PMID:31614463 Lrig1 Mouse 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of LRIG1 mRNA CTD PMID:39298647 Lrig1 Mouse 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1315602 6480464 Dihydrotestosterone results in increased expression of LRIG1 mRNA CTD PMID:29581250 Lrig1 Mouse 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 [Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of more ... CTD PMID:38995820 Lrig1 Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LRIG1 mRNA; LRIG1 affects the more ... CTD PMID:17942748|PMID:28973660 Lrig1 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases response to substance EXP 6480464 LRIG1 results in increased susceptibility to Tetrachlorodibenzodioxin CTD PMID:28973660 Lrig1 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LRIG1 mRNA CTD PMID:26290441 Lrig1 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1315602 6480464 Tetrachlorodibenzodioxin results in decreased expression of LRIG1 mRNA CTD PMID:20106945|PMID:21632981|PMID:26238291 Lrig1 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LRIG1 mRNA CTD PMID:21570461 Lrig1 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LRIG1 mRNA CTD PMID:18691609 Lrig1 Mouse 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1315602 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 Lrig1 Mouse 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4,4'-diaminodiphenylmethane results in increased expression of LRIG1 mRNA CTD PMID:18648102 Lrig1 Mouse 4,4'-sulfonyldiphenol affects methylation ISO RGD:1315602 6480464 bisphenol S affects the methylation of LRIG1 gene CTD PMID:31601247 Lrig1 Mouse 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of LRIG1 mRNA CTD PMID:28973697 Lrig1 Mouse 6-propyl-2-thiouracil decreases expression ISO RGD:1306788 6480464 Propylthiouracil results in decreased expression of LRIG1 mRNA CTD PMID:24780913 Lrig1 Mouse aflatoxin B1 decreases expression ISO RGD:1315602 6480464 Aflatoxin B1 results in decreased expression of LRIG1 mRNA CTD PMID:21641981 Lrig1 Mouse aflatoxin B1 decreases methylation ISO RGD:1315602 6480464 Aflatoxin B1 results in decreased methylation of LRIG1 gene CTD PMID:27153756 Lrig1 Mouse all-trans-retinoic acid decreases expression ISO RGD:1315602 6480464 Tretinoin results in decreased expression of LRIG1 mRNA CTD PMID:21934132 Lrig1 Mouse alpha-Zearalanol multiple interactions ISO RGD:1306788 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of LRIG1 mRNA CTD PMID:35163327 Lrig1 Mouse amphetamine decreases expression ISO RGD:1306788 6480464 Amphetamine results in decreased expression of LRIG1 mRNA CTD PMID:30779732 Lrig1 Mouse aristolochic acid A decreases expression ISO RGD:1315602 6480464 aristolochic acid I results in decreased expression of LRIG1 mRNA CTD PMID:33212167 Lrig1 Mouse arsane affects expression ISO RGD:1315602 6480464 Arsenic affects the expression of LRIG1 mRNA CTD PMID:18414638 Lrig1 Mouse arsane multiple interactions ISO RGD:1315602 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Lrig1 Mouse arsenic atom affects expression ISO RGD:1315602 6480464 Arsenic affects the expression of LRIG1 mRNA CTD PMID:18414638 Lrig1 Mouse arsenic atom multiple interactions ISO RGD:1315602 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Lrig1 Mouse benzo[a]pyrene decreases expression ISO RGD:1315602 6480464 Benzo(a)pyrene results in decreased expression of LRIG1 mRNA CTD PMID:22316170|PMID:26238291 Lrig1 Mouse benzo[a]pyrene affects methylation ISO RGD:1315602 6480464 Benzo(a)pyrene affects the methylation of LRIG1 intron CTD PMID:30157460 Lrig1 Mouse benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1315602 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LRIG1 mRNA CTD PMID:20382639 Lrig1 Mouse benzo[e]pyrene increases methylation ISO RGD:1315602 6480464 benzo(e)pyrene results in increased methylation of LRIG1 intron CTD PMID:30157460 Lrig1 Mouse bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1315602 6480464 Diethylhexyl Phthalate results in decreased expression of LRIG1 mRNA CTD PMID:31163220 Lrig1 Mouse bisphenol A decreases methylation ISO RGD:1315602 6480464 bisphenol A results in decreased methylation of LRIG1 gene CTD PMID:31601247 Lrig1 Mouse bisphenol A multiple interactions ISO RGD:1315602 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of LRIG1 gene CTD PMID:31601247 Lrig1 Mouse bisphenol F multiple interactions ISO RGD:1315602 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 Lrig1 Mouse cadmium atom multiple interactions ISO RGD:1315602 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRIG1 more ... CTD PMID:35301059 Lrig1 Mouse cadmium dichloride increases expression ISO RGD:1315602 6480464 Cadmium Chloride results in increased expression of LRIG1 mRNA CTD PMID:38382870 Lrig1 Mouse cadmium dichloride multiple interactions ISO RGD:1315602 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRIG1 more ... CTD PMID:35301059 Lrig1 Mouse cadmium dichloride decreases expression ISO RGD:1315602 6480464 Cadmium Chloride results in decreased expression of LRIG1 mRNA CTD PMID:38568856 Lrig1 Mouse calcitriol increases expression ISO RGD:1315602 6480464 Calcitriol results in increased expression of LRIG1 mRNA CTD PMID:21592394 Lrig1 Mouse calcitriol multiple interactions ISO RGD:1315602 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of LRIG1 mRNA CTD PMID:21592394 Lrig1 Mouse carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon analog results in increased expression of LRIG1 mRNA; Nanotubes, Carbon results in increased more ... CTD PMID:25620056 Lrig1 Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of LRIG1 mRNA CTD PMID:25554681 Lrig1 Mouse CGP 52608 multiple interactions ISO RGD:1315602 6480464 CGP 52608 promotes the reaction [RORA protein binds to LRIG1 gene] CTD PMID:28238834 Lrig1 Mouse ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of LRIG1 mRNA CTD PMID:18353800 Lrig1 Mouse cisplatin multiple interactions ISO RGD:1315602 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of LRIG1 mRNA; LRIG1 protein inhibits the more ... CTD PMID:21431282|PMID:27392435 Lrig1 Mouse cisplatin decreases expression ISO RGD:1315602 6480464 Cisplatin results in decreased expression of LRIG1 mRNA CTD PMID:27392435 Lrig1 Mouse cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of LRIG1 mRNA CTD PMID:21151649 Lrig1 Mouse cisplatin increases response to substance ISO RGD:1315602 6480464 LRIG1 protein results in increased susceptibility to Cisplatin CTD PMID:21431282 Lrig1 Mouse clothianidin increases expression ISO RGD:1315602 6480464 clothianidin results in increased expression of LRIG1 mRNA CTD PMID:31626844 Lrig1 Mouse copper(II) sulfate decreases expression ISO RGD:1315602 6480464 Copper Sulfate results in decreased expression of LRIG1 mRNA CTD PMID:19549813 Lrig1 Mouse coumestrol multiple interactions ISO RGD:1315602 6480464 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRIG1 mRNA; [Coumestrol co-treated with resveratrol] more ... CTD PMID:19167446 Lrig1 Mouse crocidolite asbestos decreases expression ISO RGD:1315602 6480464 Asbestos, Crocidolite results in decreased expression of LRIG1 mRNA CTD PMID:29523930 Lrig1 Mouse cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of LRIG1 mRNA CTD PMID:19770486 Lrig1 Mouse cyclosporin A decreases expression ISO RGD:1315602 6480464 Cyclosporine results in decreased expression of LRIG1 mRNA CTD PMID:25562108 Lrig1 Mouse cytarabine increases expression ISO RGD:1315602 6480464 Cytarabine results in increased expression of LRIG1 mRNA CTD PMID:21198554 Lrig1 Mouse dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of LRIG1 mRNA CTD PMID:22733784 Lrig1 Mouse dexamethasone multiple interactions ISO RGD:1315602 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 Lrig1 Mouse Dibutyl phosphate affects expression ISO RGD:1315602 6480464 di-n-butylphosphoric acid affects the expression of LRIG1 mRNA CTD PMID:37042841 Lrig1 Mouse dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of LRIG1 mRNA CTD PMID:24205000 Lrig1 Mouse dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases expression ISO RGD:1315602 6480464 Antimony Potassium Tartrate results in decreased expression of LRIG1 mRNA CTD PMID:28713220 Lrig1 Mouse dorsomorphin multiple interactions ISO RGD:1315602 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Lrig1 Mouse Enterolactone multiple interactions ISO RGD:1315602 6480464 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRIG1 mRNA CTD PMID:19167446 Lrig1 Mouse ethanol increases expression EXP 6480464 Ethanol results in increased expression of LRIG1 mRNA CTD PMID:30319688 Lrig1 Mouse ethyl methanesulfonate decreases expression ISO RGD:1315602 6480464 Ethyl Methanesulfonate results in decreased expression of LRIG1 mRNA CTD PMID:23649840 Lrig1 Mouse fenthion decreases expression EXP 6480464 Fenthion results in decreased expression of LRIG1 mRNA CTD PMID:34813904 Lrig1 Mouse fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of LRIG1 mRNA CTD PMID:28329830 Lrig1 Mouse folic acid multiple interactions EXP 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRIG1 mRNA CTD PMID:22206623 Lrig1 Mouse FR900359 increases phosphorylation ISO RGD:1315602 6480464 FR900359 results in increased phosphorylation of LRIG1 protein CTD PMID:37730182 Lrig1 Mouse fulvestrant multiple interactions ISO RGD:1315602 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of LRIG1 gene CTD PMID:31601247 Lrig1 Mouse indometacin multiple interactions ISO RGD:1315602 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 Lrig1 Mouse lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of LRIG1 mRNA CTD PMID:22613225 Lrig1 Mouse lead(0) affects expression ISO RGD:1315602 6480464 Lead affects the expression of LRIG1 mRNA CTD PMID:28903495 Lrig1 Mouse lipopolysaccharide multiple interactions ISO RGD:1315602 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRIG1 mRNA CTD PMID:35811015 Lrig1 Mouse lipopolysaccharide increases expression ISO RGD:1315602 6480464 Lipopolysaccharides results in increased expression of LRIG1 mRNA CTD PMID:35811015 Lrig1 Mouse manganese atom multiple interactions ISO RGD:1315602 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Lrig1 Mouse manganese(0) multiple interactions ISO RGD:1315602 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Lrig1 Mouse manganese(II) chloride multiple interactions ISO RGD:1315602 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Lrig1 Mouse menadione affects expression ISO RGD:1315602 6480464 Vitamin K 3 affects the expression of LRIG1 mRNA CTD PMID:20044591 Lrig1 Mouse methapyrilene increases methylation ISO RGD:1315602 6480464 Methapyrilene results in increased methylation of LRIG1 intron CTD PMID:30157460 Lrig1 Mouse methyl methanesulfonate decreases expression ISO RGD:1315602 6480464 Methyl Methanesulfonate results in decreased expression of LRIG1 mRNA CTD PMID:23649840 Lrig1 Mouse mono(2-ethylhexyl) phthalate affects expression EXP 6480464 mono-(2-ethylhexyl)phthalate affects the expression of LRIG1 mRNA CTD PMID:21195148 Lrig1 Mouse Monobutylphthalate affects expression EXP 6480464 monobutyl phthalate affects the expression of LRIG1 mRNA CTD PMID:21195148 Lrig1 Mouse N-methyl-4-phenylpyridinium increases expression ISO RGD:1315602 6480464 1-Methyl-4-phenylpyridinium results in increased expression of LRIG1 mRNA CTD PMID:24810058 Lrig1 Mouse okadaic acid increases expression ISO RGD:1315602 6480464 Okadaic Acid results in increased expression of LRIG1 mRNA CTD PMID:38832940 Lrig1 Mouse panobinostat decreases expression ISO RGD:1315602 6480464 panobinostat results in decreased expression of LRIG1 mRNA CTD PMID:26272509 Lrig1 Mouse panobinostat multiple interactions ISO RGD:1315602 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Lrig1 Mouse paracetamol increases expression ISO RGD:1306788 6480464 Acetaminophen results in increased expression of LRIG1 mRNA CTD PMID:33387578 Lrig1 Mouse perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of LRIG1 mRNA CTD PMID:36331819 Lrig1 Mouse perfluorooctanoic acid multiple interactions ISO RGD:1306788 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of LRIG1 mRNA CTD PMID:35163327 Lrig1 Mouse phenylmercury acetate decreases expression ISO RGD:1315602 6480464 Phenylmercuric Acetate results in decreased expression of LRIG1 mRNA CTD PMID:26272509 Lrig1 Mouse phenylmercury acetate multiple interactions ISO RGD:1315602 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Lrig1 Mouse pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of LRIG1 mRNA CTD PMID:18445702|PMID:20813756|PMID:23811191 Lrig1 Mouse progesterone increases expression ISO RGD:1315602 6480464 Progesterone results in increased expression of LRIG1 mRNA CTD PMID:20864642 Lrig1 Mouse quercetin decreases expression ISO RGD:1315602 6480464 Quercetin results in decreased expression of LRIG1 mRNA CTD PMID:21632981 Lrig1 Mouse raloxifene multiple interactions ISO RGD:1315602 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of LRIG1 mRNA CTD PMID:19059307 Lrig1 Mouse raloxifene affects expression ISO RGD:1315602 6480464 Raloxifene Hydrochloride affects the expression of LRIG1 mRNA CTD PMID:14699072 Lrig1 Mouse resveratrol multiple interactions ISO RGD:1315602 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of LRIG1 mRNA CTD PMID:19167446 Lrig1 Mouse S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1315602 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRIG1 mRNA CTD PMID:35811015 Lrig1 Mouse SB 431542 multiple interactions ISO RGD:1315602 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Lrig1 Mouse silicon dioxide decreases expression ISO RGD:1315602 6480464 Silicon Dioxide analog results in decreased expression of LRIG1 mRNA CTD PMID:25895662 Lrig1 Mouse SM-164 multiple interactions ISO RGD:1315602 6480464 LRIG1 protein promotes the reaction [SM 164 results in increased expression of TNF mRNA]; LRIG1 more ... CTD PMID:22241084 Lrig1 Mouse SM-164 affects response to substance ISO RGD:1315602 6480464 LRIG1 protein affects the susceptibility to SM 164 CTD PMID:22241084 Lrig1 Mouse sodium arsenite decreases expression ISO RGD:1315602 6480464 sodium arsenite results in decreased expression of LRIG1 mRNA CTD PMID:28713220 Lrig1 Mouse sodium arsenite multiple interactions ISO RGD:1315602 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Lrig1 Mouse sulforaphane increases expression ISO RGD:1315602 6480464 sulforaphane results in increased expression of LRIG1 mRNA CTD PMID:31838189 Lrig1 Mouse sunitinib decreases expression ISO RGD:1315602 6480464 Sunitinib results in decreased expression of LRIG1 mRNA CTD PMID:31533062 Lrig1 Mouse tamoxifen multiple interactions ISO RGD:1315602 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of LRIG1 mRNA CTD PMID:19059307 Lrig1 Mouse tamoxifen affects expression ISO RGD:1315602 6480464 Tamoxifen affects the expression of LRIG1 mRNA CTD PMID:14699072 Lrig1 Mouse testosterone multiple interactions ISO RGD:1315602 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of LRIG1 mRNA CTD PMID:21592394 Lrig1 Mouse testosterone increases expression ISO RGD:1315602 6480464 Testosterone results in increased expression of LRIG1 mRNA CTD PMID:21592394 Lrig1 Mouse tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of LRIG1 mRNA CTD PMID:31919559 Lrig1 Mouse titanium dioxide increases methylation EXP 6480464 titanium dioxide results in increased methylation of LRIG1 gene CTD PMID:35295148 Lrig1 Mouse trichostatin A decreases expression ISO RGD:1315602 6480464 trichostatin A results in decreased expression of LRIG1 mRNA CTD PMID:24935251|PMID:26272509 Lrig1 Mouse trichostatin A multiple interactions ISO RGD:1315602 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Lrig1 Mouse triptonide increases expression EXP 6480464 triptonide results in increased expression of LRIG1 mRNA CTD PMID:33045310 Lrig1 Mouse urethane increases expression ISO RGD:1315602 6480464 Urethane results in increased expression of LRIG1 mRNA CTD PMID:28818685 Lrig1 Mouse valproic acid increases expression ISO RGD:1315602 6480464 Valproic Acid results in increased expression of LRIG1 mRNA CTD PMID:19101580|PMID:29154799 Lrig1 Mouse valproic acid multiple interactions ISO RGD:1315602 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Lrig1 Mouse valproic acid decreases expression ISO RGD:1315602 6480464 Valproic Acid results in decreased expression of LRIG1 mRNA CTD PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369 Lrig1 Mouse valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of LRIG1 mRNA CTD PMID:17963808 Lrig1 Mouse vorinostat decreases expression ISO RGD:1315602 6480464 vorinostat results in decreased expression of LRIG1 mRNA CTD PMID:26272509 Lrig1 Mouse vorinostat multiple interactions ISO RGD:1315602 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386